Yaz FDA Warning

Yaz birth control pills, marketed by Bayer Corporation, were originally approved for marketing by the FDA in 2006. 

In October 2008, the FDA's Division of Drug Marketing, Advertising, and Communications warned Bayer that two of its direct-to-consumer television advertisements violated the FDA.  The FDA found that the T.V. ads were misleading because they broaden the drug's indication, overstate the efficacy of Yaz, and minimize the serious risks associated with the use of Yaz.

The warning specifically addressed two 60-second T.V. ads entitled "Not Gonna Take it" and "Balloons".  The FDA warned that the ads minimized the risk of Yaz in the way it communicated those risks.  Specifically, the FDA said:

The audio communication of serious risk disclosures during the "major statement" is minimized by distracting visuals, numerous scene changes, and other competing modalities such as the background music which combine to interfere with the presentation of the risk information.  In 'Not Gonna Take It", the fast-paced visuals depict various women looking at pictures, trying on clothes, chatting at a cafe, stretching/exercising in a park, and walking down the street while the audio component describes the major risks associated with Yaz...

These complex presentations disgtract from and make it difficult for viewers to process and comprehend the important risks being conveyed. This is particularly troubling as some of the risks being conveyed are serious, even life-threatening.  The overall effect of the distracting visuals, graphics, concurrent supers and background music is to undermine the communication of important risk information, minimizing these risks and misleadingly suggesting that Yaz is safer than has been demonstrated by substantial evidence or substantial clinical experience.

"Warning Letter" to Bayer HealthCare Pharmaceuticals, Inc. from FDA Division of Drug Marketing, Advertising, and Communications, October 3, 2008.

The FDA concluded by requesting that Bayer immediately discontinue the TV ads and activities for Yaz that contain the same or similar presentations.  Bayer was also required to submit a written responses within fourteen days of the warning letter.

After Bayer received this letter and as part of a settlement with the FDA and 27 states, Bayer agreed to spend at least $20 million on an ad campaign to correct the deceptive ads it had been running.  The new ads will warn that Yaz is not FDA approved to cure pimples or PMS.  Many believe however that the new ads still do not adequately warn of the dangers of Yasmin due to the progestin, drospirenone. 

Yaz/Yasmin Lawsuits

If you or a loved one suffered serious injury or a loved one died after using Yaz or Yasmin birth control pills you may be entitled to financial compensation.  Call now 888-345-5291 for a Free Yaz/Yasmin Case Evaluation.

The attorneys at the Allen Law Firm are evaluating claims on behalf of individuals throughout the United States who were prescribed Yaz or Yasmin and suffered serious side effects including blood clots, strokes, deep vein thrombosis, pulmonary embolism or death.

Fill out the form on this page or call 1-888-345-LAW1 for a free consultation

The initial consultation is free of charge.  In personal injury cases where individuals have been injured by potentially defective products like Yaz/Yasmin, it is important to act quickly to preserve evidence and investigate the the injury.  Further, you must file a lawsuit before the statute of limitations expires.  If you delay filing your claim, and the statute of limitations expires, you may lose your rights to compensation.